Results 1 to 10 of about 96,154 (100)

Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA)

Life, 2022
Background: The coronavirus disease 2019 (COVID-19) pandemic is currently ongoing, and there have been significant efforts in the development of COVID-19 vaccines.
Yuriko Terayama, Noriko Tomita, Junko Terada-Hirashima, Yukari Uemura, Yosuke Shimizu, Junko S. Takeuchi, Yuki Takamatsu, Kenji Maeda, Ayako Mikami, Mugen Ujiie, Wataru Sugiura   +10 more
doaj   +1 more source

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response

Vaccines, 2022
The long-term effect of protection by two doses of SARS-CoV-2 vaccination in patients receiving chronic intermittent hemodialysis (CIHD) is an urging question.
Sammy Patyna, Timon Eckes, Benjamin F. Koch, Stephan Sudowe, Anke Oftring, Niko Kohmer, Holger F. Rabenau, Sandra Ciesek, Despina Avaniadi, Rahel Steiner, Ingeborg A. Hauser, Josef M. Pfeilschifter, Christoph Betz   +12 more
doaj   +1 more source

Sudden Sensorineural Hearing Loss after Third Dose Booster of COVID-19 Vaccine Administration

Diagnostics, 2022
Coronavirus disease 2019 (COVID-19) was declared a pandemic due to its rapid spread worldwide, and its vaccination campaign is considered one of the most historic public hygiene measures in modern medicine.
Federica Zoccali, Francesca Cambria, Andrea Colizza, Massimo Ralli, Antonio Greco, Marco de Vincentiis, Carla Petrella, Marco Fiore, Antonio Minni, Christian Barbato   +9 more
doaj   +1 more source

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

Vaccines, 2022
The coronavirus disease 2019 (COVID-19) pandemic has become a severe healthcare problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 vaccine has been used in many countries, but it is still unable to control the ...
Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, Chompoonut Auphimai, Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Ritthideach Yorsaeng, Donchida Srimuan, Thaksaporn Thatsanatorn, Sirapa Klinfueng, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan   +14 more
doaj   +1 more source

The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis

Frontiers in Public Health, 2022
BackgroundCOVID-19 is a respiratory illness caused by SARS-CoV-2. The most recent variant is Omicron (line B.1.1.529), which was first identified in South Africa in November 2021. The concern with this variant is the ineffectiveness of vaccines currently
Yuntao Zou, Yuntao Zou, Doudou Huang, Qian Jiang, Qian Jiang, Yanglin Guo, Chider Chen, Chider Chen   +7 more
doaj   +1 more source

The importance of booster vaccination in the context of Omicron wave

Frontiers in Immunology, 2022
Omicron (B.1.1.529) was first detected in a sample collected in Botswana on November 11, 2021, and has rapidly replaced Delta as the dominant global variant given the robust transmissibility.
Zichun Wei, Jiarui He, Conghui Wang, Jiaqi Bao, Taiyang Leng, Fei Chen   +5 more
doaj   +1 more source

Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people

Frontiers in Immunology, 2023
IntroductionThe third dose of the COVID-19 vaccine is especially necessary in people over 65 years of age due to their lower immune response.MethodsWe designed a multicentre, prospective observational study including 98 people ≤65 years old who lived in ...
Iván Sanz-Muñoz, Iván Sanz-Muñoz, Rosa López-Mongil, Javier Sánchez-Martínez, Javier Sánchez-Martínez, Laura Sánchez-de Prada, Marta Domínguez-Gil González, Marta Domínguez-Gil González, Diana Pérez-SanJose, Silvia Rojo-Rello, Silvia Rojo-Rello, Cristina Hernán-García, Cristina Hernán-García, Virginia Fernández-Espinilla, Virginia Fernández-Espinilla, Raúl Ortiz de Lejarazu-Leonardo, Javier Castrodeza-Sanz, Javier Castrodeza-Sanz, José María Eiros, José María Eiros, José María Eiros   +20 more
doaj   +1 more source

Kinetics of dried blood spot-measured anti-SARS-CoV2 Spike IgG in mRNA-vaccinated healthcare workers

Frontiers in Microbiology, 2023
IntroductionOne of the major criticisms facing the research community during SARS-CoV2 pandemic was the lack of large-scale, longitudinal data on the efficacy of the SARS-CoV2 mRNA vaccines.
Lucrezia Puccini, Michela Fantini, Carlo Biagetti, Raffaella Angelini, Giorgio Dirani, Laura Grumiro, Pasqua Schiavone, Monica Sparacino, Simona Semprini, Vittorio Sambri, Vittorio Sambri, Monica Cricca, Monica Cricca   +12 more
doaj   +1 more source

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review

Tropical Medicine and Infectious Disease, 2023
As the COVID-19 pandemic continues and transitions to an endemic stage, booster vaccines will play an important role in personal and public health. However, convincing people to take boosters continues to be a key obstacle.
Yam B. Limbu, Bruce A. Huhmann
doaj   +1 more source

Assessing COVID-19 Vaccine Booster Hesitancy Using the Modified 5C Scale in Zhejiang Province, China: A Cross-Sectional Study

Vaccines, 2023
Following the rollout of a booster campaign to promote immunity against COVID-19 in China, this study aimed to assess booster hesitancy among adults who were fully vaccinated with primary doses across Zhejiang Province.
Xuan Deng, Yuchen Zhao, Shenyu Wang, Hanqing He, Zhiping Chen, Yang Zhou, Rui Yan, Xuewen Tang, Yao Zhu, Xiaoping Xu   +9 more
doaj   +1 more source